For example, both CCL2 and CCR2 are expressed in brains of patients with MS [52,53] and deletion of CCR2 leads to an almost complete inhibition of MOG35–55-induced EAE in mice [16]. This evidence concerns the gene CCL2 and myeloid sarcoma.